Richard He is an investment analyst covering life science tools and genomics stocks in the healthcare sector at T. Rowe Price Investment Management (TRPIM).

Richard’s investment experience began in 2019, and he has been with T. Rowe Price since 2024, beginning in the U.S. Equity Division. Previously, Richard was an MBA intern for T. Rowe Price Associates (TRPA) U.S. Equity Division, natural resources sector covering renewable energy technology in the summer of 2023. Prior to business school, Richard was employed by Madison Dearborn Partners as a private equity associate and at Credit Suisse as an investment banking analyst.

Richard earned an MBA/MPP from Harvard Business School where he was portfolio manager of the Alpha Investment fund and a recipient of the David M. Rubenstein Fellowship. He also earned a BA in Economics and a secondary in Philosophy from Harvard College in Cambridge, MA.